Status:

TERMINATED

Laser Treatment for Vulvar Lichen Sclerosus

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborating Sponsors:

Sciton

Conditions:

Vulvar Lichen Sclerosus

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The object of this non-randomized, prospective study is to assess the effectiveness of ablative fractional 2940 nm laser treatment of vulvar lichen sclerosus. Aim 1: To assess physical and histologic...

Detailed Description

This will be a non-randomized, open-label, prospective study. Participants will be recruited in general and subspecialty obstetrics and gynecology clinics. Participants who meet all eligibility criter...

Eligibility Criteria

Inclusion

  • We are currently recruiting Massachusetts residents only due to COVID-19.
  • Female
  • Aged 18 years old or older
  • Biopsy-proven active vulvar lichen sclerosus
  • Characteristic changes of vulvar lichen sclerosus on gynecological exam
  • Self-reported indication of one or more of the following symptoms of lichen sclerosus
  • Dryness
  • Itching
  • Burning
  • Bleeding
  • Blistering
  • Soreness
  • Easily bruises
  • Easily tears
  • Ulcerated lesions
  • Painful intercourse
  • Ability to complete questionnaires in English
  • Written, informed consent
  • Willing and able to logistically follow schedule of treatments and follow-up visits

Exclusion

  • Receiving systemic immunosuppressant's (e.g. corticosteroids) within 4 weeks of enrollment
  • Use of topical vulvar steroid-containing creams at the affected area within 4 weeks of enrollment
  • Immunocompromised (e.g. lymphoma, AIDS, Wiskott-Aldrich syndrome)
  • History of uncontrolled malignant disease
  • Additional genital skin disease
  • Known allergy or intolerance to topical anesthesia
  • Known history of connective tissue disease
  • Known propensity for keloid formations

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT04134494

Start Date

January 1 2020

End Date

December 31 2022

Last Update

June 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BIDMC

Boston, Massachusetts, United States, 02115